市場調査レポート
商品コード
1672575

光線力学療法の世界市場レポート 2025年

Photodynamic Therapy Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
光線力学療法の世界市場レポート 2025年
出版日: 2025年03月03日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

光線力学療法市場規模は、今後数年で力強い成長が見込まれます。2029年にはCAGR6.5%で20億米ドルに成長します。予測期間の成長は、ヘルスケア支出の増加、光線力学療法の保険適用、新興国における高い潜在力、10代人口の増加、高齢者人口の増加、がんや慢性疾患の有病率の増加、感染症の出現に起因すると考えられます。予測期間における主な動向としては、家庭での皮膚科的PDT治療に役立つポータブル光線力学療法デバイスのイントロダクション、患者の治療向上のための人工知能対応PDTへの投資、美容処置における製品ポートフォリオの拡大、研究開発への継続的投資、光免疫療法デバイスの提供に注力、光熱療法を含むポートフォリオの拡大などが挙げられます。

皮膚がんの罹患率の上昇が、光線力学療法(PDT)市場の成長を牽引しています。皮膚がんは最も一般的ながんとして認識されており、メラノーマは症例の約1%を占めるが、皮膚がんに関連した死亡者数は非常に多いです。PDTは、がん細胞を標的にして破壊するために、強い光と組み合わされた光増感薬を使用します。このプロセスは通常、医師が光増感剤を含むローションを皮膚がんとその周辺に塗布することから始まる。例えば、2024年1月、米国を拠点とする専門組織である米国がん協会は、皮膚がんは米国で最も罹患率の高いがんであり、メラノーマは症例の1%に過ぎないが、皮膚がんによる死亡者の大半を占めると報告しています。さらに、2024年には米国で約10万640人が新たにメラノーマと診断され、男性では約5万9170人、女性では約4万1470人が発症すると推定されています。メラノーマによる死亡者数は約8,290人と予測され、その内訳は男性約5,430人、女性約2,860人です。その結果、皮膚がんの有病率の増加が、今後数年間の光線力学療法市場の成長を大きく後押しすると予測されます。

ヘルスケア支出の増加は、今後の光線力学療法(PDT)市場の成長を後押しすると予測されています。ヘルスケア支出には、医療機器、病院サービス、医師サービス、処方薬、公衆衛生イニシアチブなど、ヘルスケア商品やサービスに割り当てられる総資金が含まれます。この支出は、研究、教育、インフラ開発、患者アクセスを促進するため、PDTの発展には不可欠です。例えば、2024年6月、英国を拠点とする非営利団体キングス・ファンド(The King's Fund)は、2022/23年、保健社会福祉省は、開業医サービス、救急車サービス、メンタルヘルス、地域ケア、病院ケアなど、さまざまな医療・介護サービスを支援するために1820億英ポンド(2,275億米ドル)を割り当てたと報告しました。さらに、2024/25年度の予算は、インフレを考慮しても前年度から11億ポンド(13億7,500万米ドル)増の1920億ポンド(2,400億米ドル)になると予測されています。この資金は、ヘルスケアサービスの質とアクセシビリティの向上を目的としており、ヘルスケア資源の改善に対する強いコミットメントを示しています。従って、医療費の増加が光線力学療法市場の拡大を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界光線力学療法PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の光線力学療法市場:成長率分析
  • 世界の光線力学療法市場の実績:規模と成長, 2019-2024
  • 世界の光線力学療法市場の予測:規模と成長, 2024-2029, 2034F
  • 世界光線力学療法総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の光線力学療法市場:製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 薬物
  • デバイス
  • 世界の光線力学療法市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 日光角化症(AK)
  • がん
  • ニキビ
  • 乾癬
  • その他の用途
  • 世界の光線力学療法市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 化粧品・皮膚科クリニック
  • 病院
  • がん治療センター
  • その他のエンドユーザー
  • 世界の光線力学療法市場、薬物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 光増感剤
  • 併用薬物療法
  • 新しい光増感剤の配合
  • 世界の光線力学療法市場、デバイスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 光源(レーザーシステム、LEDシステム)
  • 配信デバイス(光ファイバー、ハンドヘルドデバイス)
  • 治療システム(ポータブルデバイス、固定システム)

第7章 地域別・国別分析

  • 世界の光線力学療法市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の光線力学療法市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 光線力学療法市場:競合情勢
  • 光線力学療法市場:企業プロファイル
    • Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch Health Overview, Products and Services, Strategy and Financial Analysis
    • Lumenis Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Biofrontera Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Modlight Inc.
  • PhotoMedex Inc.
  • Soligenix Inc.
  • Quest PharmaTech Inc.
  • Novartis AG
  • Theralase Technologies Inc.
  • Quantel Medical
  • Axcan Pharma
  • Sihealth
  • MediGlobus
  • Steba Biotech
  • Ambicare Health
  • Nuovo Therapy
  • Pharmstandard
  • Rusatom Healthcare

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 光線力学療法市場2029:新たな機会を提供する国
  • 光線力学療法市場2029:新たな機会を提供するセグメント
  • 光線力学療法市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r25875

Photodynamic therapy (PDT) is a procedure that involves using a light source and light-sensitive medication to eliminate abnormal cells. It is applied in the treatment of certain eye and skin disorders, as well as specific types of cancers. PDT is a two-stage treatment process that combines light energy with a light-activated drug (photosensitizer) designed to destroy cancerous and precancerous cells.

The primary product categories in the photodynamic therapy market are drugs and devices. PDT drugs are light-sensitive substances that, when activated by specific types of light, work to destroy abnormal cells for the treatment of various diseases. PDT devices include lamps, LED devices, and other light-emitting devices used to activate PDT drugs. Photodynamic therapy finds applications in treating diseases such as acne, actinic keratosis, cancer, and psoriasis, among others. It is employed in various sectors, including cosmetics and dermatology clinics, hospitals, cancer treatment centers, and others.

The photodynamic therapy market research report is one of a series of new reports from The Business Research Company that provides photodynamic therapy market statistics, including photodynamic therapy industry global market size, regional shares, competitors with a photodynamic therapy market share, detailed photodynamic therapy market segments, market trends and opportunities, and any further data you may need to thrive in the photodynamic therapy industry. This photodynamic therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The photodynamic therapy market size has grown strongly in recent years. It will grow from $1.45 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to an aging population pool, an increase in cancer prevalence, an increase in skin diseases, rising pollution rates, increased healthcare expenditure, and growth in the number of healthcare facilities.

The photodynamic therapy market size is expected to see strong growth in the next few years. It will grow to $2 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the rise in healthcare expenditure, insurance coverage for photodynamic therapy, high potential in emerging economies, increasing teenage population, increasing older population, increasing prevalence of cancer and chronic diseases, and the emergence of infectious diseases. Major trends in the forecast period include the introduction of a portable photodynamic therapy device that helps in at-home dermatological PDT treatments, investing in artificial intelligence-enabled PDT for improved treatment of patients, expanding the product portfolio in cosmetic procedures, continuing investment in research and development, focusing at providing photoimmunotherapy devices and expand the portfolio to include photothermal therapy.

The rising incidence of skin cancer is driving the growth of the photodynamic therapy (PDT) market. Skin cancer is recognized as the most common form of cancer, with melanoma accounting for about 1% of cases but leading to a significant number of skin cancer-related deaths. PDT involves using a light-sensitizing medication combined with intense light to target and destroy cancer cells. This process typically begins with a doctor applying a lotion containing the light-sensitizing agent to the skin cancer and its surrounding area. For example, in January 2024, the American Cancer Society, a U.S.-based professional organization, reported that skin cancer is the most prevalent cancer in the U.S. Melanoma, while only 1% of cases, is responsible for the majority of skin cancer fatalities. Additionally, it is estimated that in 2024, there will be about 100,640 new melanoma diagnoses in the U.S., with approximately 59,170 cases in men and 41,470 in women. Around 8,290 deaths from melanoma are projected, including about 5,430 men and 2,860 women. Consequently, the increasing prevalence of skin cancer is anticipated to significantly boost the growth of the photodynamic therapy market in the coming years.

The rising healthcare expenditure is anticipated to boost the growth of the photodynamic therapy (PDT) market in the future. Healthcare expenditure encompasses the total funds allocated for healthcare goods and services, including medical equipment, hospital services, physician services, prescription drugs, and public health initiatives. This expenditure is vital for advancing photodynamic therapy as it facilitates research, education, infrastructure development, and patient access. For instance, in June 2024, The King's Fund, a UK-based non-profit organization, reported that in 2022/23, the Department for Health and Social Care allocated £182 billion ($227.5 billion) to support various health and care services, including GP services, ambulance services, mental health, community care, and hospital care. Furthermore, the budget for the 2024/25 period is projected to increase to £192 billion ($240 billion), reflecting a rise of £1.1 billion ($1.375 billion) from the previous year, even after accounting for inflation. This funding is aimed at enhancing the quality and accessibility of health services, indicating a strong commitment to improving healthcare resources. Therefore, the growing healthcare expenditure is driving the expansion of the photodynamic therapy market.

Key players in the photodynamic therapy (PDT) market are increasingly emphasizing clinical trials that explore the combination of PDT with various drugs. For example, in February 2024, Kintara Therapeutics, a US-based biotechnology company, announced the launch of a clinical trial for its REM-001 therapy, which targets cutaneous metastatic breast cancer. The clinical trial, identified as NCT05374915, is an open-label study involving 15 patients diagnosed with cutaneous metastatic breast cancer (CMBC). It aims to evaluate the efficacy of the second-generation photodynamic therapy agent REM-001 at a dosage of 0.8 mg. The trial seeks to refine the study design in preparation for a Phase 3 trial and focuses on the Best Overall Objective Response Rate (bORR) in treatment fields over a 24-week period. The primary endpoints include the assessment of complete and partial responses to the treatment.

Artificial intelligence models have demonstrated significant potential in the diagnosis and treatment of cancer. There is an increasing trend in funding aimed at enhancing product design and clinical testing, particularly in the realm of artificial intelligence applications in photodynamic therapy (PDT). AI is being utilized to examine pain and outcomes for superficial basal cell carcinomas and other diseases treated with PDT. For example, in June 2024, Biofrontera Inc., a biopharmaceutical company based in the US, introduced its FDA-approved RhodoLED XL lamp for the treatment of actinic keratosis. The FDA has authorized a new device to be used in conjunction with aminolevulinic acid hydrochloride topical gel (Ameluz) as a PDT option for mild-to-moderate actinic keratoses on the face and scalp. The RhodoLED XL commenced commercial distribution in June 2024, showcasing the company's dedication to innovation in dermatology. Its user-friendly design and features are intended to improve patient care and may set a new benchmark for PDT. The announcement emphasized the considerable advancements this lamp provides for the treatment of actinic keratosis, the most prevalent pre-cancerous skin condition.

In February 2023, Omni Partners LLP, a UK-based investment management firm, finalized the acquisition of Aesthetic Technology Ltd for an undisclosed sum. This acquisition is part of Omni Partners' strategy to enhance new technologies in healthcare, particularly those that offer effective solutions for aesthetic and medical treatments. Aesthetic Technology Limited is a UK-based manufacturer of medical equipment, focusing on innovative energy-based devices for the medical, aesthetic, and cosmetic sectors.

Major companies operating in the photodynamic therapy market include Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera, Modlight Inc., PhotoMedex Inc., Soligenix Inc., Quest PharmaTech Inc., Novartis AG, Theralase Technologies Inc., Quantel Medical, Axcan Pharma, Sihealth, MediGlobus, Steba Biotech, Ambicare Health, Nuovo Therapy, Pharmstandard, Rusatom Healthcare, Roche Latvija SIA, Hologic, Inc., Dusa Pharmaceuticals, PDT Pharma Industria e Comercio de ProdutosFarmaceuticos, MMOptics Ltd, Global Healthcare Solutions Peru, DMC Equipmentos LTDA, Biolite, SyMed LLC, Alma Lasers, Candela Medica, Velt International Group Inc.

North America was the largest region in the photodynamic therapy market in 2024. The regions covered in the photodynamic therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the photodynamic therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The photodynamic therapy market includes revenues earned by entities by treating actinic keratoses and superficial basal cell carcinomas. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Photodynamic Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on photodynamic therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for photodynamic therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The photodynamic therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Drugs, Devices
  • 2) By Application: Actinic Keratosis (AK), Cancer, Acne, Psoriasis, Other Applications
  • 3) By End-User: Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers, Other End-Users
  • Subsegments:
  • 1) By Drugs: Photosensitizers; Combination Drug Therapies; Novel Photosensitizer Formulations
  • 2) By Devices: Light Sources (Laser Systems, LED Systems); Delivery Devices (Fiber Optics, Handheld Devices); Treatment Systems (Portable Devices, Fixed Systems)
  • Companies Mentioned: Galderma S.A., Bausch Health, Lumenis Ltd., Sun Pharmaceutical Industries Ltd., Biofrontera; Modlight Inc.; PhotoMedex Inc.; Soligenix Inc.; Quest PharmaTech Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Photodynamic Therapy Market Characteristics

3. Photodynamic Therapy Market Trends And Strategies

4. Photodynamic Therapy Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Photodynamic Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Photodynamic Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Photodynamic Therapy Market Growth Rate Analysis
  • 5.4. Global Photodynamic Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Photodynamic Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Photodynamic Therapy Total Addressable Market (TAM)

6. Photodynamic Therapy Market Segmentation

  • 6.1. Global Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drugs
  • Devices
  • 6.2. Global Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Actinic Keratosis (AK)
  • Cancer
  • Acne
  • Psoriasis
  • Other Applications
  • 6.3. Global Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cosmetics And Dermatology Clinics
  • Hospitals
  • Cancer Treatment Centers
  • Other End-Users
  • 6.4. Global Photodynamic Therapy Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Photosensitizers
  • Combination Drug Therapies
  • Novel Photosensitizer Formulations
  • 6.5. Global Photodynamic Therapy Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Light Sources (Laser Systems, LED Systems)
  • Delivery Devices (Fiber Optics, Handheld Devices)
  • Treatment Systems (Portable Devices, Fixed Systems)

7. Photodynamic Therapy Market Regional And Country Analysis

  • 7.1. Global Photodynamic Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Photodynamic Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Photodynamic Therapy Market

  • 8.1. Asia-Pacific Photodynamic Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Photodynamic Therapy Market

  • 9.1. China Photodynamic Therapy Market Overview
  • 9.2. China Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Photodynamic Therapy Market

  • 10.1. India Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Photodynamic Therapy Market

  • 11.1. Japan Photodynamic Therapy Market Overview
  • 11.2. Japan Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Photodynamic Therapy Market

  • 12.1. Australia Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Photodynamic Therapy Market

  • 13.1. Indonesia Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Photodynamic Therapy Market

  • 14.1. South Korea Photodynamic Therapy Market Overview
  • 14.2. South Korea Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Photodynamic Therapy Market

  • 15.1. Western Europe Photodynamic Therapy Market Overview
  • 15.2. Western Europe Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Photodynamic Therapy Market

  • 16.1. UK Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Photodynamic Therapy Market

  • 17.1. Germany Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Photodynamic Therapy Market

  • 18.1. France Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Photodynamic Therapy Market

  • 19.1. Italy Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Photodynamic Therapy Market

  • 20.1. Spain Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Photodynamic Therapy Market

  • 21.1. Eastern Europe Photodynamic Therapy Market Overview
  • 21.2. Eastern Europe Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Photodynamic Therapy Market

  • 22.1. Russia Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Photodynamic Therapy Market

  • 23.1. North America Photodynamic Therapy Market Overview
  • 23.2. North America Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Photodynamic Therapy Market

  • 24.1. USA Photodynamic Therapy Market Overview
  • 24.2. USA Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Photodynamic Therapy Market

  • 25.1. Canada Photodynamic Therapy Market Overview
  • 25.2. Canada Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Photodynamic Therapy Market

  • 26.1. South America Photodynamic Therapy Market Overview
  • 26.2. South America Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Photodynamic Therapy Market

  • 27.1. Brazil Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Photodynamic Therapy Market

  • 28.1. Middle East Photodynamic Therapy Market Overview
  • 28.2. Middle East Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Photodynamic Therapy Market

  • 29.1. Africa Photodynamic Therapy Market Overview
  • 29.2. Africa Photodynamic Therapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Photodynamic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Photodynamic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Photodynamic Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Photodynamic Therapy Market Competitive Landscape
  • 30.2. Photodynamic Therapy Market Company Profiles
    • 30.2.1. Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bausch Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lumenis Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Biofrontera Overview, Products and Services, Strategy and Financial Analysis

31. Photodynamic Therapy Market Other Major And Innovative Companies

  • 31.1. Modlight Inc.
  • 31.2. PhotoMedex Inc.
  • 31.3. Soligenix Inc.
  • 31.4. Quest PharmaTech Inc.
  • 31.5. Novartis AG
  • 31.6. Theralase Technologies Inc.
  • 31.7. Quantel Medical
  • 31.8. Axcan Pharma
  • 31.9. Sihealth
  • 31.10. MediGlobus
  • 31.11. Steba Biotech
  • 31.12. Ambicare Health
  • 31.13. Nuovo Therapy
  • 31.14. Pharmstandard
  • 31.15. Rusatom Healthcare

32. Global Photodynamic Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Photodynamic Therapy Market

34. Recent Developments In The Photodynamic Therapy Market

35. Photodynamic Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Photodynamic Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Photodynamic Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Photodynamic Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer